Needle phobia: confronting a neglected factor in travel vaccine hesitancy.
BACKGROUND: Patients with needle phobia present with disproportionate fear, anxiety, or avoidance of needles that can disrupt access to healthcare services. Needle phobia creates a barrier to public health measures including travel vaccine uptake. This narrative review analyses these challenges by examining the psychological, sociocultural, and clinical determinants of needle phobia and how they can be addressed in travel medicine practice. METHODS: The literature search was performed using PubMed, Scopus, and Google Scholar databases. Only articles published in English were included, with a focus on work published in the last 10 years to align with advancements in vaccine technology and psychological interventions for needle phobia. Key data extracted from studies included population characteristics, prevalence and severity of needle phobia, intervention strategies, vaccine hesitancy trends, and emerging vaccine technologies. RESULTS: Individuals with needle phobia are twice as likely to be vaccine hesitant as non-phobic individuals. Needle phobia often originates from a learned fear response, with 62-81% beginning in childhood, decreases with age, and has a higher prevalence among females (up to two-fold). Prior fainting is more than twice as common in travellers who fear injections (16.5% vs 6.9%). Therapeutic support includes pain management techniques that minimise the physical and psychological discomfort associated with vaccination, distraction interventions, graduated exposure therapy, and applied tension that counteracts vasovagal syncope by using muscle tension techniques. Non-injection vaccine modalities such as oral, intranasal, and microarray patch vaccines may alleviate needle phobia and enhance vaccine compliance. Advances in vaccination technology have the potential to revolutionise how vaccines are administered in travel medicine practice. CONCLUSIONS: Needle phobia represents a significant and often overlooked barrier to vaccine uptake. Addressing this issue requires the integration of both clinical and psychological interventions, along with the adoption of promising technological advancements in vaccine delivery.
Authors
- Gerard Thomas Flaherty (ORCID: https://orcid.org/0000-0002-5987-1658)
- Lin Hwei Chen (ORCID: https://orcid.org/0000-0002-5684-8436)
- Aonghus J. Feeney (ORCID: https://orcid.org/0009-0001-5178-7814)
- Mary T McAuliffe
Institutions
- Mount Auburn Hospital (US)
- Harvard University (US)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Mahidol University (TH)
- British Association for Behavioural and Cognitive Psychotherapies (GB)
- IMU University (MY)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1093/jtm/taag107
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00